Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Percutaneous aortic valve replacement].

Eberhard Grube1, Ulrich Gerckens, Lutz Buellesfeld

  • 1Medizinische Klinik - Kardiologie und Angiologie, HELIOS Klinikum Siegburg, Ringstrasse 49, 53721 Siegburg. GrubeE@aol.com

Herz
|October 31, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Impact of Myocardium at Risk in Transcatheter Aortic Valve Implantation.

Circulation. Cardiovascular interventions·2026
Same author

Predicting the Surge in Valve-in-Valve Volume: A Comparative Study of Japan and the United States.

JACC. Asia·2025
Same author

Three-Year Outcomes With a Supra-Annular, Self-Expanding Bioprosthesis and a Pericardial Wrap-The FORWARD PRO Study.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2024
Same author

Transcatheter Aortic Valve Replacement in Patients at High Risk of Coronary Obstruction.

Journal of the Society for Cardiovascular Angiography & Interventions·2024
Same author

Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.

European heart journal·2024
Same author

Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study.

JACC. Cardiovascular interventions·2024

Percutaneous aortic valve replacement offers a less invasive alternative to surgery for high-risk patients with aortic valve stenosis. Ongoing device development aims to expand its use in the future.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • Surgical aortic valve replacement is the standard treatment for symptomatic aortic valve disease.
  • High-risk patients face significant perioperative mortality (up to 50%) with surgical replacement.
  • Percutaneous valve replacement presents a less invasive alternative.

Purpose of the Study:

  • To evaluate the efficacy and safety of percutaneous valve replacement techniques.
  • To discuss the evolution of balloon-expandable and self-expanding valve prostheses.
  • To highlight the limitations and future directions of percutaneous aortic valve replacement.

Main Methods:

  • Evaluation of balloon-expandable valve prostheses since 2002 in high-risk patients.
  • Modifications in implantation techniques and prosthesis design.

Related Experiment Videos

  • Assessment of a novel self-expanding valve prosthesis in a First-in-Man Study.

    • Main Results:

    • Procedural success rates exceeding 75% with adverse event rates below 20% at 30 days for modified balloon-expandable valves.
    • Demonstrated feasibility of the self-expanding valve prosthesis technique.
    • Current limitations include strict inclusion criteria for both percutaneous approaches.

    Conclusions:

    • Percutaneous aortic valve replacement is a viable, less invasive option for select high-risk patients.
    • Technological advancements are improving procedural success and safety.
    • Future developments are expected to broaden the application of percutaneous valve replacement.